Cited by 233Ovarian function and disordersGenetic and Kidney Cyst DiseasesSexual Differentiation and Disorders

The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.

The Role of Genes and Environment in the Etiology of PCOS

Diamanti-Kandarakis, Evanthia, Kandarakis, Helen, Legro, Richard S.·2006·Endocrine

Open this paper in CoChat — free account

Abstract

Both genes and the environment contribute to PCOS. Obesity, exacerbated by poor dietary choices and physical inactivity, worsens PCOS in susceptible individuals. The role of other environmental modifiers such as infectious agents or toxins are speculative. Phenotype confusion has characterized genetic studies of PCOS. Although several loci have been proposed as PCOS genes including CYP11A, the insulin gene, the follistatin gene, and a region near the insulin receptor, the evidence supporting linkage is not overwhelming. The strongest case can be made for the region near the insulin receptor gene (but not involving this gene), as it has been identified in two separate studies, and perhaps most importantly has not yet been refuted by larger studies. However, the responsible gene at chromosome 19p13.3 remains to be identified. To date, no gene has been identified that causes or contributes substantially to the development of a PCOS phenotype.

Integrity signals

Registry

Crossref · 10.1385/endo:30:1:19

Cites

52 of 52 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)
The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group (2004) · Human Reproduction · doi:10.1093/humrep/deh098 · Cited by 6,138
Genetic Dissection of Complex Traits
Lander, E. S., & Schork, N. J. (1994) · Science · doi:10.1126/science.8091226 · Cited by 3,425
Association study designs for complex diseases
Cardon, L. R., & Bell, J. I. (2001) · Nature Reviews Genetics · doi:10.1038/35052543 · Cited by 1,395
Ultrasound assessment of the polycystic ovary: international consensus definitions
Balen, A. H., Laven, J. S. E., Tan, S.-L., & Dewailly, D. (2003) · Human Reproduction Update · doi:10.1093/humupd/dmg044 · Cited by 1,015
Improvement in Endocrine and Ovarian Function during Dietary Treatment of Obese Women with Polycystic Ovary Syndrome
Kiddy, D. S., Hamilton‐Fairley, D., Bush, A., Short, F., Anyaoku, V., Reed, M. J., & Franks, S. (1992) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1992.tb02909.x · Cited by 921
The TDT and other family-based tests for linkage disequilibrium and association.
(1996) · PubMed Central · Cited by 901
Evidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome
Legro, R. S., Driscoll, D., Strauss, J. F., Fox, J., & Dunaif, A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.25.14956 · Cited by 699
Self-citation
Polycystic Ovaries and Hyperandrogenism in Women Taking Valproate for Epilepsy
Isojärvi, J. I. T., Laatikainen, T., Pakarinen, A., Juntunen, K., & Myllylä, V. V. (1993) · New England Journal of Medicine · doi:10.1056/nejm199311043291904 · Cited by 688
Heritability of polycystic ovary syndrome in a Dutch twin-family study
Vink, J. M., Sadrzadeh, S., Lambalk, C. B., & Boomsma, D. I. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1494 · Cited by 647
Dietary Composition in Restoring Reproductive and Metabolic Physiology in Overweight Women with Polycystic Ovary Syndrome
Moran, L. J., Noakes, M., Clifton, P. M., Tomlinson, L., & Norman, R. J. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020815 · Cited by 530

Show all 52 references

Sorted by citations

Metabolic dysfunction in polycystic ovary syndrome: Pathogenic role of androgen excess and potential therapeutic strategies
Sanchez-Garrido, M. A., & Tena-Sempere, M. (2020) · Molecular Metabolism · doi:10.1016/j.molmet.2020.01.001 · Cited by 557
Zonulin, a regulator of epithelial and endothelial barrier functions, and its involvement in chronic inflammatory diseases
Sturgeon, C., & Fasano, A. (2016) · Tissue Barriers · doi:10.1080/21688370.2016.1251384 · Cited by 497
Polycystic ovary syndrome (PCOS) and genetic predisposition: A review article
Ajmal, N., Khan, S. Z., & Shaikh, R. (2019) · European Journal of Obstetrics & Gynecology and Reproductive Biology X · doi:10.1016/j.eurox.2019.100060 · Cited by 298
Sheep models of polycystic ovary syndrome phenotype
Padmanabhan, V., & Veiga‐Lopez, A. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2012.10.005 · Cited by 222
The management of patients with polycystic ovary syndrome
Jayasena, C. N., & Franks, S. (2014) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2014.102 · Cited by 196
A meta-analysis of pregnancy-related outcomes and complications in women with polycystic ovary syndrome undergoing IVF
Sha, T., Wang, X., Cheng, W., & Yan, Y. (2019) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2019.03.203 · Cited by 187
Nutritional Supplements and Complementary Therapies in Polycystic Ovary Syndrome
Alesi, S., Ee, C., Moran, L., Rao, V. S., & Mousa, A. (2021) · Advances in Nutrition · doi:10.1093/advances/nmab141 · Cited by 191
DNA methylation in the pathogenesis of polycystic ovary syndrome
Vázquez-Martínez, E. R., Gómez-Viais, Y. I., García-Gómez, E., Reyes-Mayoral, C., Reyes-Muñoz, E., Camacho‐Arroyo, I., & Cerbón, M. A. (2019) · Reproduction · doi:10.1530/rep-18-0449 · Cited by 111
Pathogenesis of polycystic ovary syndrome: multifactorial assessment from the foetal stage to menopause
de Melo, A. S., Dias, S. V., Cavalli, R. D. C., Cardoso, V. C., Bettiol, H., Barbieri, M. A., Ferriani, R. A., & Vieira, C. S. (2015) · Reproduction · doi:10.1530/rep-14-0499 · Cited by 99
Aromatase inhibitors for PCOS: a systematic review and meta-analysis
Misso, M. L., Wong, J. L. A., Teede, H. J., Hart, R. J., Rombauts, L. J. F., Melder, A., Norman, R. J., & Costello, M. (2012) · Human Reproduction Update · doi:10.1093/humupd/dms003 · Cited by 96
Serum Metabolomics Study of Polycystic Ovary Syndrome Based on Liquid Chromatography–Mass Spectrometry
Zhao, X., Xu, F., Qi, B., Hao, S., Li, Y., Li, Y., Zou, L., Caixia, L., Xu, G., & Hou, L. (2014) · Journal of Proteome Research · doi:10.1021/pr401130w · Cited by 90
Linkage of regulators of TGF‐β activity in the fetal ovary to polycystic ovary syndrome
Hatzirodos, N., Bayne, R. A. L., Irving‐Rodgers, H. F., Hummitzsch, K., Sabatier, L., Lee, S. S., Bonner, W. M., Gibson, M. A., Rainey, W. E., Carr, B. R., et al. (2011) · The FASEB Journal · doi:10.1096/fj.11-181099 · Cited by 90
Myo‐inositol and D‐chiro‐inositol (40:1) reverse histological and functional features of polycystic ovary syndrome in a mouse model
Bevilacqua, A., Dragotto, J., Giuliani, A., & Bizzarri, M. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27623 · Cited by 85
Gene Expression in Granulosa Cells From Small Antral Follicles From Women With or Without Polycystic Ovaries
Owens, L. A., Kristensen, S. G., Lerner, A., Christopoulos, G., Lavery, S., Hanyaloglu, A. C., Hardy, K., Yding Andersen, C., & Franks, S. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-00780 · Cited by 85
Use of metformin before and during assisted reproductive technology in non-obese young infertile women with polycystic ovary syndrome: a prospective, randomized, double-blind, multi-centre study
Kjøtrød, S., Carlsen, S. M., Rasmussen, P. E., Holst-Larsen, T., Mellembakken, J. R., Thurin‐Kjellberg, A., HaapaniemiKouru, K., Morin-Papunen, L. C., Humaidan, P., Sunde, A. L., et al. (2011) · Human Reproduction · doi:10.1093/humrep/der154 · Cited by 82
Polycystic Ovary Syndrome: Do Endocrine-Disrupting Chemicals Play a Role?
Sobolewski, M., & Barrett, E. S. (2014) · Seminars in Reproductive Medicine · doi:10.1055/s-0034-1371088 · Cited by 81
An update of polycystic ovary syndrome: causes and therapeutics options
Rababa’h, A. M., Matani, B. R., & Yehya, A. (2022) · Heliyon · doi:10.1016/j.heliyon.2022.e11010 · Cited by 90
An update on polycystic ovary syndrome: A review of the current state of knowledge in diagnosis, genetic etiology, and emerging treatment options
Islam, H., Masud, J., Islam, Y. N., & Haque, F. K. M. (2022) · Women s Health · doi:10.1177/17455057221117966 · Cited by 98
A review on critical appraisal and pathogenesis of polycystic ovarian syndrome
Hajam, Y. A., Rather, H., Neelam, N., Kumar, R., Basheer, M., & Reshi, M. S. (2024) · Endocrine and Metabolic Science · doi:10.1016/j.endmts.2024.100162 · Cited by 86
Genome-Wide Methylated DNA Immunoprecipitation Analysis of Patients with Polycystic Ovary Syndrome
Shen, H., Qiu, L., Zhang, Z.-Q., Qin, Y., Cao, C., & Di, W. J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064801 · Cited by 70
Urinary concentration of personal care products and polycystic ovary syndrome: A case-control study
Gu, J., Yuan, T., Ni, N., Ma, Y., Shen, Z., Yu, X., Shi, R., Tian, Y., Zhou, W., & Zhang, J. (2018) · Environmental Research · doi:10.1016/j.envres.2018.09.014 · Cited by 71
Chronic Inflammation in PCOS: The Potential Benefits of Specialized Pro-Resolving Lipid Mediators (SPMs) in the Improvement of the Resolutive Response
Regidor, P., Mueller, A., Sailer, M., Santos, F. G., Rizo, J. M., & Egea, F. M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms22010384 · Cited by 70
Cardio-Metabolic Disease and Polycystic Ovarian Syndrome (PCOS): A Narrative Review
Sangaraju, S. L., Yepez, D., Grandes, X. A., Manjunatha, R. T., & Habib, S. (2022) · Cureus · doi:10.7759/cureus.25076 · Cited by 77
Comprehensive analysis of genome-wide DNA methylation across human polycystic ovary syndrome ovary granulosa cell
Xu, J., Bao, X., Peng, Z., Wang, L., Du, L., Niu, W., & Sun, Y. (2016) · Oncotarget · doi:10.18632/oncotarget.8544 · Cited by 64
Prenatal Exposure to Endocrine Disruptors: A Developmental Etiology for Polycystic Ovary Syndrome
Hewlett, M., Chow, E., Aschengrau, A., & Mahalingaiah, S. (2017) · Reproductive Sciences · doi:10.1177/1933719116654992 · Cited by 61
Complex diseases and co-morbidities: polycystic ovary syndrome and type 2 diabetes mellitus
Rodgers, R. J., Avery, J. C., Moore, V. M., Davies, M. J., Azziz, R., Stener-Victorin, E., Moran, L. J., Robertson, S. A., Stepto, N. K., Norman, R. J., et al. (2019) · Endocrine Connections · doi:10.1530/ec-18-0502 · Cited by 60
Harmful and beneficial effects of inflammatory response on reproduction: sterile and pathogen-associated inflammation
Negishi, Y., Shima, Y., Takeshita, T., & Morita, R. (2020) · Immunological Medicine · doi:10.1080/25785826.2020.1809951 · Cited by 62
Inositols’ Importance in the Improvement of the Endocrine–Metabolic Profile in PCOS
Wojciechowska, A., Osowski, A., Jóźwik, M., Górecki, R. J., Rynkiewicz, A., & Wojtkiewicz, J. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20225787 · Cited by 64
The Experience of Women Affected by Polycystic Ovary Syndrome: A Qualitative Study From Iran
Amiri, F. N., Tehrani, F. R., Simbar, M., Montazeri, A., & Mohammadpour, R. A. (2014) · Intern J Endocrinol Metab · doi:10.5812/ijem.13612 · Cited by 59
High copper levels in follicular fluid affect follicle development in polycystic ovary syndrome patients: Population-based and in vitro studies
Sun, Y., Wang, W., Guo, Y., Zheng, B., Li, H., Chen, J., & Zhang, W. (2019) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2019.01.008 · Cited by 55
Impaired CFTR-Dependent Amplification of FSH-Stimulated Estrogen Production in Cystic Fibrosis and PCOS
Chen, H., Guo, J. H., Lü, Y., Ding, G. L., Yu, M., Tsang, L. L., Fok, K. L., Liu, X. M., Zhang, X., Chung, Y. W., et al. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-1363 · Cited by 53
Association of vitamin D receptor gene variants with polycystic ovary syndrome: a meta-analysis
Shi, X.-Y., Huang, A.-P., Xie, D., & Yu, X. (2019) · BMC Medical Genetics · doi:10.1186/s12881-019-0763-5 · Cited by 52
Digit ratios do not serve as anatomical evidence of prenatal androgen exposure in clinical phenotypes of polycystic ovary syndrome
Lujan, M. E., Bloski, T. G., Chizen, D. R., Lehotay, D. C., & Pierson, R. A. (2010) · Human Reproduction · doi:10.1093/humrep/dep363 · Cited by 49
Afamin serum concentrations are associated with insulin resistance and metabolic syndrome in polycystic ovary syndrome
Seeber, B., Morandell, E., Lunger, F., Wildt, L., & Dieplinger, H. (2014) · Reproductive Biology and Endocrinology · doi:10.1186/1477-7827-12-88 · Cited by 48
The WNT/β-catenin signaling pathway may be involved in granulosa cell apoptosis from patients with PCOS in North China
Wu, X., Wang, Y.-Q., Xu, S., Liu, J.-L., Bi, X.-Y., Wang, Z.-Q., & Zhang, J.-P. (2015) · Journal of Gynecology Obstetrics and Human Reproduction · doi:10.1016/j.jgyn.2015.08.013 · Cited by 47
Vitamin D receptor polymorphisms and the polycystic ovary syndrome: A systematic review
dos Reis, G. V. O. P., Gontijo, N. A., Rodrigues, K. F., Alves, M. T., Ferreira, C. N., & Gomes, K. B. (2017) · Journal of obstetrics and gynaecology research · doi:10.1111/jog.13250 · Cited by 47
Physiology and Pathology of the Female Reproductive Axis
Bulun, S. E. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-0324-5.00017-1 · Cited by 40
Improvements in PCOS characteristics and phenotype severity during a randomized controlled lifestyle intervention
Dietz de Loos, A. L. P., Jiskoot, G., Timman, R., Beerthuizen, A., Busschbach, J. J. V., & Laven, J. S. E. (2021) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2021.05.008 · Cited by 39
HMGB1 is increased in adolescents with polycystic ovary syndrome (PCOS) and decreases after treatment with myo-inositol (MYO) in combination with alpha-lipoic acid (ALA)
Cirillo, F., Catellani, C., Lazzeroni, P., Sartori, C., Tridenti, G., Vezzani, C., Fulghesu, A. M., Madeddu, E., Amarri, S., & Street, M. E. (2020) · Gynecological Endocrinology · doi:10.1080/09513590.2020.1725967 · Cited by 39
High dietary copper intake induces perturbations in the gut microbiota and affects host ovarian follicle development
Wang, Q., Sun, Y., Zhao, A., Cai, X.-F., Yu, A., Xu, Q., Liu, W., Zhang, N., Wu, S., Chen, Y., et al. (2023) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2023.114810 · Cited by 40
Body Mass Index and Gonadotropin Hormones (LH & FSH) Associate With Clinical Symptoms Among Women With Polycystic Ovary Syndrome
Esmaeilzadeh, S., Andarieh, M. G., Ghadimi, R., & Delavar, M. A. (2014) · Global Journal of Health Science · doi:10.5539/gjhs.v7n2p101 · Cited by 38
Association of luteinizing hormone/choriogonadotropin receptor gene polymorphisms with polycystic ovary syndrome risk: a meta-analysis
Zou, J., Wu, D., Liu, Y., & Tan, S. (2018) · Gynecological Endocrinology · doi:10.1080/09513590.2018.1498834 · Cited by 38
Changes in individual polycystic ovary syndrome phenotypical characteristics over time: a long-term follow-up study
van Keizerswaard, J., de Loos, A. D., Louwers, Y. V., & Laven, J. S. E. (2022) · Fertility and Sterility · doi:10.1016/j.fertnstert.2022.01.014 · Cited by 42
Cellular reprogramming for understanding and treating human disease
Kanherkar, R. R., Bhatia‐Dey, N., Makarev, E., & Csoka, A. B. (2014) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2014.00067 · Cited by 37
Status of clomiphene citrate and metformin for infertility in PCOS
Misso, M. L., Teede, H. J., Hart, R. J., Wong, J., Rombauts, L. J. F., Melder, A., Norman, R. J., & Costello, M. (2012) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2012.07.001 · Cited by 37
Quantitative Differences in TGF-β Family Members Measured in Small Antral Follicle Fluids From Women With or Without PCO
Kristensen, S. G., Kumar, A., Kalra, B., Pors, S. E., Bøtkjær, J. A., Mamsen, L. S., Colmorn, L. B., Fedder, J., Ernst, E., Owens, L. A., et al. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-01094 · Cited by 35
Role of genomic DNA methylation in PCOS pathogenesis: a systematic review and meta-analysis involving case-controlled clinical studies
Rawat, K., Sandhu, A., Gautam, V., Saha, P. K., & Saha, L. (2022) · Molecular Human Reproduction · doi:10.1093/molehr/gaac024 · Cited by 34
Metabolic health during a randomized controlled lifestyle intervention in women with PCOS
Dietz de Loos, A., Jiskoot, G., Beerthuizen, A., Busschbach, J., & Laven, J. (2022) · European Journal of Endocrinology · doi:10.1530/eje-21-0669 · Cited by 33
Experimental models of polycystic ovary syndrome: An update
Divyashree, S., Janhavi, P., Veeranna, R. P., & Peddha, M. S. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.116911 · Cited by 33
Implication of thymoquinone as a remedy for polycystic ovary in rat
Arif, M., Thakur, S. C., & Datta, K. (2015) · Pharmaceutical Biology · doi:10.3109/13880209.2015.1072565 · Cited by 33
High Doses of D-Chiro-Inositol Alone Induce a PCO-Like Syndrome and Other Alterations in Mouse Ovaries
Bevilacqua, A., Dragotto, J., Lucarelli, M., Emidio, G. D., Monastra, G., & Tatone, C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115691 · Cited by 32
Telomeric repeat‐containing RNA ( TERRA ) related to polycystic ovary syndrome ( PCOS )
Wang, C., Shen, F., Zhu, Y., Fang, Y., & Lü, S. (2016) · Clinical Endocrinology · doi:10.1111/cen.13283 · Cited by 31
Identifying genes associated with the development of human polycystic ovary syndrome
Saddick, S. (2020) · Saudi Journal of Biological Sciences · doi:10.1016/j.sjbs.2020.01.012 · Cited by 31
Potentials of curcumin against polycystic ovary syndrome: Pharmacological insights and therapeutic promises
Akter, T., Zahan, M. S., Nawal, N. N. A., Rahman, M. H., Tanjum, T. N., Arafat, K. I., Moni, A., Islam, M. N., & Uddin, M. J. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e16957 · Cited by 31
Could perturbed fetal development of the ovary contribute to the development of polycystic ovary syndrome in later life?
Hartanti, M. D., Rosario, R., Hummitzsch, K., Bastian, N. A., Hatzirodos, N., Bonner, W. M., Bayne, R. A. L., Irving‐Rodgers, H. F., Anderson, R. A., & Rodgers, R. J. (2020) · PLoS ONE · doi:10.1371/journal.pone.0229351 · Cited by 26
Natural history of polycystic ovary syndrome: A systematic review of cardiometabolic outcomes from longitudinal cohort studies
Kiconco, S., Tay, C. T., Rassie, K. L., Azziz, R., Teede, H. J., & Joham, A. E. (2022) · Clinical Endocrinology · doi:10.1111/cen.14647 · Cited by 25
Digit ratios by computer-assisted analysis confirm lack of anatomical evidence of prenatal androgen exposure in clinical phenotypes of polycystic ovary syndrome
Lujan, M. E., Podolski, A. J., Chizen, D. R., Lehotay, D. C., & Pierson, R. A. (2010) · Reproductive Biology and Endocrinology · doi:10.1186/1477-7827-8-156 · Cited by 24
Polymorphisms and haplotypes of insulin-like factor 3 gene are associated with risk of polycystic ovary syndrome in Indian women
Shaikh, N. J., Dadachanji, R., Meherji, P. K., Shah, N. S., & Mukherjee, S. (2015) · Gene · doi:10.1016/j.gene.2015.11.033 · Cited by 22
Association of three missense mutations in the homocysteine-related MTHFR and MTRR gene with risk of polycystic ovary syndrome in Southern Chinese women
Feng, W.-Q., Zhang, Y., Pan, Y., Zhang, Y., Liu, M., Huang, Y., Xiao, Y., Mo, W., Jiao, J., Wang, X., et al. (2021) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-020-00688-8 · Cited by 22
Physiology and Pathology of the Female Reproductive Axis
Bulun, S. E. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-29738-7.00017-4 · Cited by 22
The effects of N-acetylcysteine supplement on metabolic parameters in women with polycystic ovary syndrome: a systematic review and meta-analysis
Liu, J., Su, H., Jin, X., Wang, L., & Huang, J. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1209614 · Cited by 23
The Impact of High BMI on Pregnancy Outcomes and Complications in Women with PCOS Undergoing IVF—A Systematic Review and Meta-Analysis
Alenezi, S. A., Khan, R. N., & Amer, S. A. K. S. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13061578 · Cited by 24
Effects of Flax Seeds Supplementation in PolyCystic Ovarian Syndrome
Fatima Farzana, K., Abubacker Sulaiman, F., Ruckmani, A., Vijayalakshmi, K. S., Karunya Lakshmi, G., Shri Ranjini, S., & Duraivel, M. (2015) · Cited by 21
The Effect of Clomiphene Citrate Versus Letrozole on Pregnancy Rate in Women With Polycystic Ovary Syndrome: A Randomized Clinical Trial
Behnoud, N., Farzaneh, F., & Ershadi, S. (2019) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 21
PCOS: A Chronic Disease That Fails to Produce Adequately Specialized Pro-Resolving Lipid Mediators (SPMs)
Regidor, P., de la Rosa, X., Müller, A., Mayr, M., Santos, F. G., Banzo, R. G., & Rizo, J. M. (2022) · Biomedicines · doi:10.3390/biomedicines10020456 · Cited by 22
A meta-analysis of the association of ApaI, BsmI, FokI, and TaqI polymorphisms in the vitamin D receptor gene with the risk of polycystic ovary syndrome in the Eastern Mediterranean Regional Office population
Shahmoradi, A., Aghaei, A., Ghaderi, K., Rezaei, M. J., & Azarnezhad, A. (2022) · International Journal of Reproductive BioMedicine (IJRM) · doi:10.18502/ijrm.v20i6.11439 · Cited by 20
Lack of Association of Vitamin D Receptor FokI (rs10735810) (C/T) and BsmI (rs1544410) (A/G) Genetic Variations with Polycystic Ovary Syndrome Risk: a Case-control Study from Iranian Azeri Turkish Women.
Bagheri, M., Rad, I. A., Jazani, N. H., & Nanbakhsh, F. (2012) · Europe PMC (PubMed Central) · Cited by 20
Early onset adiposity: a pathway to polycystic ovary syndrome in adolescents?
Diamanti‐Kandarakis, E., Christakou, C. D., Kandaraki, E., & Alexandraki, K. (2007) · PubMed · Cited by 20
Self-citation
Anti-Müllerian hormone gene polymorphism is associated with androgen levels in Chinese polycystic ovary syndrome patients with insulin resistance
Zheng, M., Li, Y., Hu, R., Wang, F., Zhang, X., & Guan, B. (2016) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-015-0641-9 · Cited by 20
RETRACTED: High fructose-enriched diet synergistically exacerbates endocrine but not metabolic changes in letrozole-induced polycystic ovarian syndrome in Wistar rats
Akintayo, C. O., Johnson, A. D., Badejogbin, O. C., Olaniyi, K. S., Oniyide, A. A., Ajadi, I. O., Ojewale, A. O., Adeyomoye, O., & Kayode, A. B. (2021) · Heliyon · doi:10.1016/j.heliyon.2020.e05890 · Cited by 20
Retracted
Assessment of Early Markers of Cardiovascular Risk in Polycystic Ovary Syndrome
Alexandraki, K., Eleitho Practice, A., Kandaraki, E., Poulia, K., Piperi, C., Papadimitriou, E., & Papaioannou, T. (2021) · touchREVIEWS in Endocrinology · doi:10.17925/ee.2021.17.1.37 · Cited by 19
The effects of N-acetylcysteine on ovulation and sex hormones profile in women with polycystic ovary syndrome: a systematic review and meta-analysis
Asl, Z. S., Parastouei, K., & Eskandari, E. (2023) · British Journal Of Nutrition · doi:10.1017/s0007114522003270 · Cited by 24
Urinary Metabolites Reveal Hyperinsulinemia and Insulin Resistance in Polycystic Ovarian Syndrome (PCOS)
Fulghesu, A. M., Piras, C., Dessì, A., Succu, C., Atzori, L., Pintus, R., Gentile, C., Angioni, S. L., & Fanos, V. (2021) · Metabolites · doi:10.3390/metabo11070437 · Cited by 20
The plasminogen activator inhibitor-1 (PAI-1) gene −844 A/G and −675 4G/5G promoter polymorphism significantly influences plasma PAI-1 levels in women with polycystic ovary syndrome
Sun, L., Zhang, H., Liu, B., Wei, W., & Yongmei, G. (2009) · Endocrine · doi:10.1007/s12020-009-9255-2 · Cited by 19
Clinical-exome sequencing unveils the genetic landscape of polycystic ovarian syndrome (PCOS) focusing on lean and obese phenotypes: implications for cost-effective diagnosis and personalized treatment
Dhar, S., & Bhattacharjee, P. (2024) · Scientific Reports · doi:10.1038/s41598-024-75719-0 · Cited by 18
To Study The Status of LH: FSH Ratio in Obese And Non-Obese Patients of Polycystic Ovarian Syndrome
Lal, L., Bharti, A., & Perween, A. (2017) · IOSR Journal of Dental and Medical Sciences · doi:10.9790/0853-1601012023 · Cited by 16
Association of Estrogen Receptor Genes Polymorphisms With Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis Based on Observational Studies
Zhou, S., Wen, S., Sheng, Y., Yang, M., Shen, X., Chen, Y., Kang, D., & Xu, L. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.726184 · Cited by 16
Machine learning techniques for medical images in PCOS
Makhdoomi, A., Jan, N., Palak, P., & Goel, N. (2022) · International Conference on Artificial Intelligence and Speech Technology (AIST) · doi:10.1109/aist55798.2022.10064817 · Cited by 16
Diabetes mellitus: Complications, emerging therapeutic targets, and evolving treatment approaches
Mohd, S., Kumar, L. L., Harish, V., Kumar, R., Chaudhary, A., & Sharma, V. (2025) · Obesity Medicine · doi:10.1016/j.obmed.2025.100652 · Cited by 20
Fat mass and Obesity Associated (FTO) gene and polycystic ovary syndrome: Insight into pathogenesis and association with insulin resistance
Parveen, S., Khan, S., Ahsan, H., Manger, P. T., Gupta, B., & Alam, R. (2022) · Human Nutrition & Metabolism · doi:10.1016/j.hnm.2022.200174 · Cited by 17
Investigation of the FSHR, CYP11, and INSR Mutations and Polymorphisms in Iranian Infertile Women with Polycystic Ovary Syndrome (PCOS)
Abutorabi, E. S., Rashidi, B. H., Irani, S., Haghollahi, F., & Bagheri, M. (2021) · Reports of Biochemistry and Molecular Biology · doi:10.52547/rbmb.9.4.470 · Cited by 15
Dose Dependent Effects of Aqueous Extract of Garcinia cambogia Desr. Against Letrozole Induced Polycystic Ovarian Syndrome in Female Adult Rats With Possible Mechanisms Exploration
Rana, S., Hussain, L., Saleem, U., Asif, M., Lodhi, A. H., Barkat, M. Q., Riaz, M. S., & Jamil, A. (2023) · Dose-Response · doi:10.1177/15593258231169381 · Cited by 15
Can resistance training improve the symptoms of polycystic ovary syndrome?
Pericleous, P., & Stephanides, S. (2018) · BMJ Open Sport & Exercise Medicine · doi:10.1136/bmjsem-2018-000372 · Cited by 15
Inflammatory responses in early pregnancy: Physiological and pathological perspectives
Negishi, Y., & Morita, R. (2024) · Reproductive Medicine and Biology · doi:10.1002/rmb2.12619 · Cited by 17
Efficacy of a Proprietary Fenugreek Seed Extract ( Trigonella foenum-graecum , Furocyst®) in Women with Polycystic Ovary Syndrome (PCOS): a Randomized, Double-Blind, Placebo-Controlled Study
Singh, A., Gainder, S., Banerjee, P., Goel, A., Kumar, P., Mondal, B., Banik, S. P., & Bagchi, D. (2022) · Journal of the American Nutrition Association · doi:10.1080/27697061.2022.2126410 · Cited by 14
A Review and Meta-Analysis of the Prevalence and Health Impact of Polycystic Ovary Syndrome Among Medical and Dental Students
Coffin, T., Wray, J., Sah, R., Maj, M. C., Nath, R., Nauhria, S., Maity, S., & Nauhria, S. (2023) · Cureus · doi:10.7759/cureus.40141 · Cited by 18
Genetic variants of metabolism and inflammatory pathways, and PCOS risk –Systematic review, meta-analysis, and in-silico analysis
Sharma, P. P., Bhatia, K., Kapoor, H. S., Kaur, B., & Khetarpal, P. (2023) · Gene · doi:10.1016/j.gene.2023.147796 · Cited by 14
A review of antioxidant N-acetylcysteine in addressing polycystic ovary syndrome
Yifu, P. (2024) · Gynecological Endocrinology · doi:10.1080/09513590.2024.2381498 · Cited by 14
Waist hip ratio: an anatomical predictive marker of risk of PCOS
Yadav, S., & Tarware, R. (2019) · International Journal of Reproduction Contraception Obstetrics and Gynecology · doi:10.18203/2320-1770.ijrcog20191231 · Cited by 14
Polycystic ovary syndrome
Maharaj, S., & Amod, A. (2009) · Journal of Endocrinology Metabolism and Diabetes of South Africa · doi:10.1080/22201009.2009.10872199 · Cited by 14
Cut‐off value for anti‐Müllerian hormone in the diagnostic criteria for polycystic ovary syndrome in the Japanese population
Noguchi, H., Iwasa, T., Iwase, A., Kanasaki, H., Kimura, F., Kugu, K., Saito, K., Baba, T., Hara, T., & Matsuzaki, T. (2024) · Journal of obstetrics and gynaecology research · doi:10.1111/jog.15972 · Cited by 13
Can polyunsaturated fatty acids regulate Polycystic Ovary Syndrome via TGF-β signalling?
Prabhu, Y. D., & Gopalakrishnan, A. V. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119416 · Cited by 15
Where are we in understanding the natural history of polycystic ovary syndrome? A systematic review of longitudinal cohort studies
Kiconco, S., Tay, C. T., Rassie, K. L., Azziz, R., Teede, H. J., & Joham, A. E. (2022) · Human Reproduction · doi:10.1093/humrep/deac077 · Cited by 13
The impact of polycystic ovary syndrome on women’s quality of life: Nursing guidelines for its
Hassan, H. E., & Farag, D. S. S. (2019) · Clinical Nursing Studies · doi:10.5430/cns.v7n3p42 · Cited by 13
Association of single nucleotide polymorphisms in the RAB5B gene 3′UTR region with polycystic ovary syndrome in Chinese Han women
Yu, J., Ding, C., Guan, S., & Wang, C. (2019) · Bioscience Reports · doi:10.1042/bsr20190292 · Cited by 12
Relationship of insulin resistance with recurrent pregnancy loss
Wani, A. A., Gul, I. A., Jabeen, F., Kaul, S., Lone, F. A., & Akhter, G. (2017) · International Journal of Reproduction Contraception Obstetrics and Gynecology · doi:10.18203/2320-1770.ijrcog20171384 · Cited by 12
Impaired Respiratory Function in Women With PCOS Compared With Matched Controls From a Population-Based Study
Underdal, M. O., Salvesen, Ø. O., Henriksen, A. H., Andersen, M., & Vanky, E. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgz053 · Cited by 11
Genetic polymorphisms associated with polycystic ovary syndrome among Iranian women
Jamshidi, M., Pour, S. M., Bahadoram, M., Mahmoudian‐Sani, M., & Saeedi‐Boroujeni, A. (2020) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.13534 · Cited by 12
Molecular docking and pharmacology study to explore bio-active compounds and underlying mechanisms of Caesalpinia bonducella on polycystic ovarian syndrome
Hossain, M. A., Sharfaraz, A., Hasan, M. I., Somadder, P. D., Haque, M. A., Sarker, M. R., Alam, M. M., Hasan, A. M. W., Sohel, M. M. H., & Rahman, M. H. (2022) · Informatics in Medicine Unlocked · doi:10.1016/j.imu.2022.101073 · Cited by 11
Comparing efficacy and safety of stair step protocols for clomiphene citrate and letrozole in ovulation induction for women with polycystic ovary syndrome (PCOS): a randomized controlled clinical trial
Al-Thuwaynee, S., & Swadi, A. A. J. (2023) · Journal of Medicine and Life · doi:10.25122/jml-2023-0069 · Cited by 17

Authors: Diamanti-Kandarakis, E., Kandarakis, H., & Legro, R. S.
Affiliations: National and Kapodistrian University of Athens (GR)
Corresponding author: Legro, Richard S.
ORCID: Legro, Richard S.
Venue: Endocrine
Publisher: Springer Science and Business Media LLC
Published: 2006
Volume: 30
Issue: 1
Pages: 19-26
ISSN: 0969-711X (ISSN-L)
DOI: 10.1385/endo:30:1:19
OpenAlex: W1975207893
Cited by: 233
References: 52
Citations by year: 2026: 4 · 2025: 19 · 2024: 26 · 2023: 25 · 2022: 23 · 2021: 23 · 2020: 15 · 2019: 24 · 2018: 6 · 2017: 7 · 2016: 10 · 2015: 10 · 2014: 8 · 2013: 9 · 2012: 6
FWCI: 3.52
Type: journal article
Language: en
Open access: closed
Locations: Endocrine (publishedVersion)
PubMed (publishedVersion)
Funders: Pennsylvania State University
Deutsches Krebsforschungszentrum
National Center for Research Resources (M01 RR10732, M01RR010732)
Eunice Kennedy Shriver National Institute of Child Health and Human Development (U54-HD34449, K24 HD01476, U54HD034449, K24HD001476)
Topics: Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic and Kidney Cyst Diseases
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Sexual Differentiation and Disorders
Keywords: polycystic ovary syndrome, etiology, genetic susceptibility, environmental factors, obesity, insulin resistance, insulin receptor gene, CYP11A, follistatin, chromosome 19p13.3, genetic linkage, infectious agents, toxins
MeSH terms: Cholesterol Side-Chain Cleavage Enzyme, Chromosomes, Human, 19-20, Environment, Family, Female, Humans, Insulin, Obesity, Polycystic Ovary Syndrome, Receptor, Insulin, Genetic Predisposition to Disease, Follistatin

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The Role of Genes and Environment in the Etiology of PCOS

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Citations

Cites

Cited by

Related

Metadata

Record

About these checks